Annual Report

Overview

The report highlights PolyNovo's strong FY24 growth, with Total Group Revenue of $104.8m and NovoSorb sales growth of 54.5%. The company reports that its products and training have reached over 50,000 patients across 41 countries. Its ESG disclosures cover environmental initiatives, workforce diversity, community support, bioethics, and modern slavery, including a 42% women share across all employees. The report also states that zero lost-time injuries and zero medical-treatment injuries occurred among employees and contractors during FY24.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services